Publications by authors named "P Talavera"

Claim this Profile
E
Early and late onset cardiotoxicity following anthracycline-based chemotherapy in breast cancer patients: Incidence and predictors.
José M Serrano, Rebeca Mata, Iria González, Silvia Del Castillo, Javier Muñiz, Pedro Talavera

Int J Cardiol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical, Patient-Reported, and Ultrasound Outcomes from an Open-Label, 12-week Observational Study of Certolizumab Pegol in Spanish Patients with Rheumatoid Arthritis with or without Prior Anti-TNF Exposure.
Francisco J Blanco, Esteban Rubio-Romero, Raimon Sanmartí, César Díaz-Torné, Pablo Talavera

Reumatol Clin (Engl Ed)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical, Ultrasound, and Predictability Outcomes Following Certolizumab Pegol Treatment (with Methotrexate) in Patients with Moderate-to-Severe Rheumatoid Arthritis: 52-Week Results from the CZP-SPEED Study.
Piercarlo Sarzi-Puttini, Emilio Filippucci, Silvano Adami, Pier Luigi Meroni, Alberto Batticciotto, Pablo Talavera

Adv Ther· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of new-onset benign anal disorders after bariatric surgery.
O Cano-Valderrama, A Sánchez-Pernaute, M A Rubio, P Talavera, E Martín-Antona

Clin Obes· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A consortium-driven framework to guide the implementation of ICH M7 Option 4 control strategies.
Chris Barber, Vincent Antonucci, Jens-Christoph Baumann, Roland Brown, Elizabeth Covey-Crump, Pere Talavera

Regul Toxicol Pharmacol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis